Avanos Medical Stock EBITDA
| 8HH Stock | EUR 17.60 0.20 1.15% |
Avanos Medical fundamentals help investors to digest information that contributes to Avanos Medical's financial success or failures. It also enables traders to predict the movement of Avanos Stock. The fundamental analysis module provides a way to measure Avanos Medical's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Avanos Medical stock.
Avanos |
Avanos Medical Company EBITDA Analysis
Avanos Medical's EBITDA stands for earnings before interest, taxes, depreciation, and amortization. It is a measure of a company operating cash flow based on data from the company income statement and is a very good way to compare companies within industries or across different sectors. However, unlike Operating Cash Flow, EBITDA does not include the effects of changes in working capital.
Current Avanos Medical EBITDA | 47.4 M |
Most of Avanos Medical's fundamental indicators, such as EBITDA, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Avanos Medical is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
In a nutshell, EBITDA is calculated by adding back each of the excluded items to the post-tax profit, and can be used to compare companies with very different capital structures.
| Competition |
According to the company disclosure, Avanos Medical reported earnings before interest,tax, depreciation and amortization of 47.4 M. This is 94.6% lower than that of the Healthcare sector and 89.92% lower than that of the Medical Instruments & Supplies industry. The ebitda for all Germany stocks is 98.78% higher than that of the company.
Avanos EBITDA Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Avanos Medical's direct or indirect competition against its EBITDA to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Avanos Medical could also be used in its relative valuation, which is a method of valuing Avanos Medical by comparing valuation metrics of similar companies.Avanos Medical is currently under evaluation in ebitda category among its peers.
Avanos Fundamentals
| Return On Equity | 0.0348 | |||
| Return On Asset | 0.0236 | |||
| Profit Margin | 0.06 % | |||
| Operating Margin | 0.08 % | |||
| Current Valuation | 1.35 B | |||
| Shares Outstanding | 46.5 M | |||
| Shares Owned By Insiders | 1.65 % | |||
| Shares Owned By Institutions | 95.00 % | |||
| Price To Earning | 108.36 X | |||
| Price To Book | 0.97 X | |||
| Price To Sales | 1.50 X | |||
| Revenue | 744.6 M | |||
| Gross Profit | 364.3 M | |||
| EBITDA | 47.4 M | |||
| Net Income | 5.2 M | |||
| Cash And Equivalents | 288.1 M | |||
| Cash Per Share | 6.05 X | |||
| Total Debt | 130 M | |||
| Debt To Equity | 25.60 % | |||
| Current Ratio | 3.06 X | |||
| Book Value Per Share | 27.11 X | |||
| Cash Flow From Operations | 87.3 M | |||
| Earnings Per Share | 0.87 X | |||
| Target Price | 43.0 | |||
| Number Of Employees | 4.55 K | |||
| Beta | 0.9 | |||
| Market Capitalization | 1.32 B | |||
| Total Asset | 1.59 B | |||
| Z Score | 6.0 | |||
| Net Asset | 1.59 B |
About Avanos Medical Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Avanos Medical's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Avanos Medical using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Avanos Medical based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
Additional Information and Resources on Investing in Avanos Stock
When determining whether Avanos Medical is a strong investment it is important to analyze Avanos Medical's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Avanos Medical's future performance. For an informed investment choice regarding Avanos Stock, refer to the following important reports:Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Avanos Medical. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors. For more detail on how to invest in Avanos Stock please use our How to Invest in Avanos Medical guide.You can also try the Technical Analysis module to check basic technical indicators and analysis based on most latest market data.